176 related articles for article (PubMed ID: 35572560)
1. Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells.
Wang Q; Huang C; Ding Y; Wen S; Wang X; Guo S; Gao Q; Chen Z; Zhao Y; Wang M; Shen B; Zhu W
Front Immunol; 2022; 13():884373. PubMed ID: 35572560
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W
Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322
[No Abstract] [Full Text] [Related]
3. Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer.
Wang Q; Huang C; Wang D; Tao Z; Zhang H; Zhao Y; Wang M; Zhou C; Xu J; Shen B; Zhu W
Cell Signal; 2023 Jun; 106():110639. PubMed ID: 36842523
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer mesenchymal stem cells via the CXCR2/HK2/PD-L1 pathway mediate immunosuppression.
Huang C; Chen B; Wang X; Xu J; Sun L; Wang D; Zhao Y; Zhou C; Gao Q; Wang Q; Chen Z; Wang M; Zhang X; Xu W; Shen B; Zhu W
Gastric Cancer; 2023 Sep; 26(5):691-707. PubMed ID: 37300724
[TBL] [Abstract][Full Text] [Related]
5. [Conditional medium of gastric cancer mesenchymal stem cells promotes PD-L1 expression in gastric cancer cells and tumor growth via upregulating VGLL4].
Ding Y; Zhu W; Wang Q; Chen B; Wang M; Zhao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):321-327. PubMed ID: 35583061
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells.
Gao Q; Huang C; Liu T; Yang F; Chen Z; Sun L; Zhao Y; Wang M; Luo L; Zhou C; Zhu W
J Cell Biochem; 2024 Mar; 125(3):e30521. PubMed ID: 38226525
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
[TBL] [Abstract][Full Text] [Related]
8. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.
Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S
Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344
[TBL] [Abstract][Full Text] [Related]
9. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.
He W; Liang B; Wang C; Li S; Zhao Y; Huang Q; Liu Z; Yao Z; Wu Q; Liao W; Zhang S; Liu Y; Xiang Y; Liu J; Shi M
Oncogene; 2019 Jun; 38(23):4637-4654. PubMed ID: 30742067
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
Van Der Kraak L; Goel G; Ramanan K; Kaltenmeier C; Zhang L; Normolle DP; Freeman GJ; Tang D; Nason KS; Davison JM; Luketich JD; Dhupar R; Lotze MT
J Immunother Cancer; 2016; 4():65. PubMed ID: 27777774
[TBL] [Abstract][Full Text] [Related]
11. Impacts of hyperthermic chemotherapeutic agent on cytotoxicity, chemoresistance-related proteins and PD-L1 expression in human gastric cancer cells.
Su BC; Chen GY; Yang CM; Chuang WT; Lin MC; Hsu PL; Lee CW; Cheng CC; Wu SY; Pan BS; Yu HH
Int J Hyperthermia; 2024; 41(1):2310017. PubMed ID: 38350654
[No Abstract] [Full Text] [Related]
12. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells.
Gao L; Guo Q; Li X; Yang X; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Xi T; Zheng L
EBioMedicine; 2019 Mar; 41():395-407. PubMed ID: 30803931
[TBL] [Abstract][Full Text] [Related]
13. Enhanced gastric cancer growth potential of mesenchymal stem cells derived from gastric cancer tissues educated by CD4
Xu R; Zhao X; Zhao Y; Chen B; Sun L; Xu C; Shen B; Wang M; Xu W; Zhu W
Cell Prolif; 2018 Apr; 51(2):e12399. PubMed ID: 29057538
[TBL] [Abstract][Full Text] [Related]
14. Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis.
Sun L; Wang Q; Chen B; Zhao Y; Shen B; Wang H; Xu J; Zhu M; Zhao X; Xu C; Chen Z; Wang M; Xu W; Zhu W
Cell Death Dis; 2018 Sep; 9(9):928. PubMed ID: 30206229
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
16. MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer.
Chen Z; Xu P; Wang X; Li Y; Yang J; Xia Y; Wang S; Liu H; Xu Z; Li Z
Cancer Lett; 2023 Jul; 565():216235. PubMed ID: 37209945
[TBL] [Abstract][Full Text] [Related]
17. PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression.
Wu L; Cai S; Deng Y; Zhang Z; Zhou X; Su Y; Xu D
Int Immunopharmacol; 2021 May; 94():107443. PubMed ID: 33581579
[TBL] [Abstract][Full Text] [Related]
18. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
[TBL] [Abstract][Full Text] [Related]
19. ATXN2-Mediated PI3K/AKT Activation Confers Gastric Cancer Chemoresistance and Attenuates CD8
Wang Q; Cao T; Zhang X; Hui J; Wang C; Zhang W; Wang P; Zhou Y; Han S
J Immunol Res; 2022; 2022():6863240. PubMed ID: 36213324
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer.
Yan XL; Luo QY; Zhou SN; Pan WT; Zhang L; Yang DJ; Qiu MZ
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101574. PubMed ID: 33272890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]